Variant report
Variant | esv3440109 |
---|---|
Chromosome Location | chr6:65355631-65362329 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113933410 | chr6:65356085-65356086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370911144 | chr6:65356091-65356092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548897195 | chr6:65356151-65356152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373304076 | chr6:65356229-65356230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567209893 | chr6:65356256-65356257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559572254 | chr6:65356289-65356290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533465182 | chr6:65356296-65356297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182947025 | chr6:65356321-65356322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570177079 | chr6:65356324-65356325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376878608 | chr6:65356337-65356338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549946733 | chr6:65356341-65356342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200957774 | chr6:65356342-65356343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549884050 | chr6:65356355-65356356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571310022 | chr6:65356372-65356373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2009850 | chr6:65356383-65356384 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs535438068 | chr6:65356416-65356417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572098714 | chr6:65356418-65356419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536238350 | chr6:65356425-65356426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs78386234 | chr6:65356467-65356468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574383024 | chr6:65356487-65356488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187292404 | chr6:65356489-65356490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572271513 | chr6:65356496-65356497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs578083532 | chr6:65356523-65356524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545503601 | chr6:65356590-65356591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1813560 | chr6:65356591-65356592 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs527716489 | chr6:65356611-65356612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548958387 | chr6:65356616-65356617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560898342 | chr6:65356654-65356655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374798509 | chr6:65356701-65356702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76120748 | chr6:65356716-65356717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531639098 | chr6:65356750-65356751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116228084 | chr6:65356848-65356849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149787533 | chr6:65356857-65356858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10944658 | chr6:65356908-65356909 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs145782221 | chr6:65356937-65356938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565771040 | chr6:65356944-65356945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs13218461 | chr6:65357003-65357004 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs552686408 | chr6:65357032-65357033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13202049 | chr6:65357033-65357034 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs9345341 | chr6:65357118-65357119 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs191741256 | chr6:65357122-65357123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs578147148 | chr6:65357129-65357130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148927866 | chr6:65357176-65357177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144216572 | chr6:65357181-65357182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9452282 | chr6:65357182-65357183 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs62417975 | chr6:65357212-65357213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542666165 | chr6:65357222-65357223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560957826 | chr6:65357232-65357233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371469782 | chr6:65357233-65357234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531573226 | chr6:65357249-65357250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65356000-65356800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr6:65356800-65358000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr6:65358200-65358400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |